Why MedTech Portfolios Underperform: What Investors and Analysts Often Miss
A Measurement Problem—Not a Talent or Technology Problem By Andjela Azabagic As an investor or board member in healthcare and medical technology, you are not just funding innovation—you are underwriting uncertainty. Across my career bringing healthcare products to market and advising both established companies and early-stage ventures, I’ve seen a recurring pattern: technically strong products stall not because they lack clinical value, but because they are evaluated and gove
Dec 18, 20253 min read
The Obelisk: A New AI–Human Efficiency Model
A recent Harvard Business Review article caught my attention for how clearly it articulated a shift I’ve been watching unfold for years: artificial intelligence is not just changing consulting—it’s reshaping the very structure of knowledge-based work. The conversation around AI often swings between two extremes. On one end is the fear that AI will replace professionals altogether. On the other is the belief that it will simply make us more indispensable. Having observed this
Dec 18, 20252 min read
Making Sense of the Diagnostic Imaging “Tetris Board”
At the annual RSNA meeting — the Radiological Society of North America’s conference , one of the world’s largest gatherings of medical imaging professionals — I heard the same comment over and over again: “This feels overwhelming.” RSNA brings together tens of thousands of physicians, hospital leaders, researchers, and technology companies from around the world to showcase the latest advances in medical imaging. With so many innovations on display, it can feel like staring at
Dec 16, 20252 min read
From Diagnosis to Prevention: A New Paradigm for Longevity
From Diagnosis to Prevention: The Key to Longevity Over the past 20 years, heart imaging has quietly gone through a major transformation. What once required invasive tests or only showed problems after symptoms appeared has evolved into something far more powerful: a way to see heart disease early — often before it causes damage. In 2021, that shift became official. Major medical organizations recommended cardiac CT angiography (CCTA) as a first-line test for evaluating stabl
Dec 15, 20253 min read
